Answer
Serious post-injection reactions have been reported within minutes after Rekambys (rilpivirine) injections in clinical studies and were very rare.
Sources for this answer
- Rekambys 900 mg prolonged-release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked